AU2005205880B2 - Compounds for the sustained reduction of body weight - Google Patents

Compounds for the sustained reduction of body weight Download PDF

Info

Publication number
AU2005205880B2
AU2005205880B2 AU2005205880A AU2005205880A AU2005205880B2 AU 2005205880 B2 AU2005205880 B2 AU 2005205880B2 AU 2005205880 A AU2005205880 A AU 2005205880A AU 2005205880 A AU2005205880 A AU 2005205880A AU 2005205880 B2 AU2005205880 B2 AU 2005205880B2
Authority
AU
Australia
Prior art keywords
tropane
body weight
compound
use according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005205880A
Other languages
English (en)
Other versions
AU2005205880A1 (en
Inventor
Ole Graff
Birgit Ohrt Mikkelsen
Stephane Pollentier
Morten Priskorn
Andreas Raschig
Juergen Reess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of AU2005205880A1 publication Critical patent/AU2005205880A1/en
Application granted granted Critical
Publication of AU2005205880B2 publication Critical patent/AU2005205880B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2005205880A 2004-01-22 2005-01-11 Compounds for the sustained reduction of body weight Ceased AU2005205880B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04001282.5 2004-01-22
EP04001282 2004-01-22
EP04005816 2004-03-11
EP04005816.6 2004-03-11
PCT/EP2005/000165 WO2005070427A1 (en) 2004-01-22 2005-01-11 Compounds for the sustained reduction of body weight

Publications (2)

Publication Number Publication Date
AU2005205880A1 AU2005205880A1 (en) 2005-08-04
AU2005205880B2 true AU2005205880B2 (en) 2010-06-10

Family

ID=34809747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005205880A Ceased AU2005205880B2 (en) 2004-01-22 2005-01-11 Compounds for the sustained reduction of body weight

Country Status (7)

Country Link
US (1) US20050203124A1 (enExample)
EP (1) EP1727547A1 (enExample)
JP (1) JP2007519646A (enExample)
AU (1) AU2005205880B2 (enExample)
CA (1) CA2553649A1 (enExample)
NZ (1) NZ547919A (enExample)
WO (1) WO2005070427A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003762A (es) * 2003-10-16 2006-06-14 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de recaptacion de neurotransmisor monoamina y un inhibidor de acetilcolinesterasa.
AU2005205882A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
EP1779851A1 (en) * 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes
EP2222303A1 (en) * 2007-11-20 2010-09-01 NeuroSearch A/S A method for treating addiction
WO2009065845A1 (en) * 2007-11-20 2009-05-28 Neurosearch A/S A method for treating over-eating disorders
EP2237781A2 (en) * 2007-12-20 2010-10-13 NeuroSearch A/S Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity
WO2009080693A2 (en) * 2007-12-20 2009-07-02 Neurosearch A/S Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker
WO2013120935A1 (en) 2012-02-16 2013-08-22 Neurosearch A/S Pharmaceutical compositions for combination therapy
LT3265126T (lt) 2015-03-03 2021-09-10 Saniona A/S Tesofensino ir metoprololio derinio kompozicija
MX2021004737A (es) * 2018-10-24 2021-06-04 Saniona As Composiciones de tropano transdermicas y metodos para usar las mismas.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030997A1 (en) * 1996-02-22 1997-08-28 Neurosearch A/S Tropane-derivatives, their preparation and use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897922B1 (en) * 1991-11-15 2005-07-20 Research Triangle Institute Cocaine receptor binding ligands
US5554626A (en) * 1992-12-23 1996-09-10 Neurosearch A/S Substituted heterocyclic compounds as dopamine-reuptake inhibitors
DK154192D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Heterocycliske forbindelser
CZ284379B6 (cs) * 1994-04-19 1998-11-11 Neurosearch A/S Tropanové deriváty, způsob jejich přípravy a jejich použití
US6262081B1 (en) * 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
JP2005508872A (ja) * 2001-05-23 2005-04-07 ニューロサーチ、アクティーゼルスカブ トロパン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害剤として使用する方法
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
EP1594874A1 (en) * 2003-02-12 2005-11-16 Neurosearch A/S Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
MXPA06003762A (es) * 2003-10-16 2006-06-14 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de recaptacion de neurotransmisor monoamina y un inhibidor de acetilcolinesterasa.
AU2005205882A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
WO2005117874A1 (en) * 2004-06-04 2005-12-15 Neurosearch A/S MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR FOR THE INHIBITION OF BETA-AMYLOID (Aß40 AND Aß42) -GENERATION

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030997A1 (en) * 1996-02-22 1997-08-28 Neurosearch A/S Tropane-derivatives, their preparation and use

Also Published As

Publication number Publication date
NZ547919A (en) 2009-12-24
WO2005070427A8 (en) 2005-11-17
JP2007519646A (ja) 2007-07-19
EP1727547A1 (en) 2006-12-06
AU2005205880A1 (en) 2005-08-04
WO2005070427A1 (en) 2005-08-04
CA2553649A1 (en) 2005-08-04
US20050203124A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
JP6170040B2 (ja) ピルフェニドン及び選択された患者における抗線維化療法
US20080051443A1 (en) Compounds for the reduction of excessive food intake
US20090068290A1 (en) Bifeprunox doses for treating schizophrenia
US20220016055A1 (en) Pharmaceutical Compositions For Combination Therapy
AU2005205880B2 (en) Compounds for the sustained reduction of body weight
TW201632511A (zh) 治療精神分裂症之組成物及方法
KR20250108755A (ko) 시누클레인병변을 치료하기 위한 조성물 및 방법
EP3982963B1 (en) Composition comprising pridopidine and analog thereof for treating huntington disease and symptoms thereof
JP2010501626A (ja) 統合失調症を処置するためのビフェプルノックス用量
TWI803488B (zh) Nk-1拮抗劑組合及治療突觸核蛋白病症之方法
KR102870956B1 (ko) 조현병의 치료를 위한 일로페리돈
KR20170117185A (ko) 스트레스-유도성 p-tau 를 낮추는 트리아졸로피리딘 및 트리아졸로피리미딘
CA2519584A1 (en) Pramipexole for reducing excessive food intake by children
JP7535797B2 (ja) 化合物バフィデムスタット（ｖａｆｉｄｅｍｓｔａｔ）などｋｄｍ１ａ阻害剤を使用した注意欠陥多動性障害の処置方法
JP2019524682A (ja) 抗うつ作用の速い発現のためのボルチオキセチン投与計画
JP2008501656A (ja) β−アミロイド（Ａβ４０及びＡβ４２）生成阻害のためのモノアミン神経伝達物質再取り込み阻害剤
US20080200498A1 (en) Pharmaceutical Composition For The Treatment Of Disorders Of Sexual Desire
MXPA06008205A (en) Compounds for the sustained reduction of body weight
MX2011010030A (es) Medicamento novedoso para el tratamiento del deterioro cognitivo.
US20040266794A1 (en) Pramipexole for the reduction of excessive food intake for children
TW201134818A (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for administration shortly after amiodarone discontinuation
KR20220108123A (ko) 치매 환자의 행동 및 심리적 증상 치료
JP2010501604A (ja) グルコースレベルを低下させる方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired